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Abstract
Objective
High plantar pressures are implicated in the development of diabetes-related foot ulcers.
Whether plantar pressures remain high in patients with chronic diabetes-related foot ulcers
over time is uncertain. The primary aim of this study was to compare plantar pressures at
baseline and three and six months later in participants with chronic diabetes-related foot
ulcers (cases) to participants without foot ulcers (controls).
Methods
Standardised protocols were used to measure mean peak plantar pressure and pressure-
time integral at 10 plantar foot sites (the hallux, toes, metatarsals 1 to 5, mid-foot, medial
heel and lateral heel) during barefoot walking. Measurements were performed at three
study visits: baseline, three and six months. Linear mixed effects random-intercept models
were utilised to assess whether plantar pressures differed between cases and controls after
adjusting for age, sex, body mass index, neuropathy status and follow-up time. Standard-
ised mean differences (Cohen’s d) were used to measure effect size.
Results
Twenty-one cases and 69 controls started the study and 16 cases and 63 controls com-
pleted the study. Cases had a higher mean peak plantar pressure at several foot sites
PLOS ONE | https://doi.org/10.1371/journal.pone.0181916 August 31, 2017 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Fernando ME, Crowther RG, Lazzarini PA,
Yogakanthi S, Sangla KS, Buttner P, et al. (2017)
Plantar pressures are elevated in people with
longstanding diabetes-related foot ulcers during
follow-up. PLoS ONE 12(8): e0181916. https://doi.
org/10.1371/journal.pone.0181916
Editor: Yih-Kuen Jan, University of Illinois at
Urbana-Champaign, UNITED STATES
Received: March 28, 2017
Accepted: June 9, 2017
Published: August 31, 2017
Copyright: © 2017 Fernando et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data are available at
http://dx.doi.org/10.4225/28/58ffdc3d4403f, Digital
Object Identifier (DOI): 10.4225/28/58ffdc3d4403f.
Funding: Funding from the Department of Health,
Queensland Government under the Health
Practitioner Research Grant Scheme (2013-2014),
funding from the Graduate Research School,
James Cook University and funding from the
National Health and Medical Research Council
supported this work. JG holds a Practitioner
Fellowships from the National Health and Medical
including the toes (p = 0.005, Cohen’s d = 0.36) and mid-foot (p = 0.01, d = 0.36) and a
higher pressure-time integral at the hallux (p<0.001, d = 0.42), metatarsal 1 (p = 0.02, d =
0.33) and mid-foot (p = 0.04, d = 0.64) compared to controls throughout follow-up. A reduc-
tion in pressure-time integral at multiple plantar sites over time was detected in all partici-
pants (p<0.05, respectively).
Conclusions
Plantar pressures assessed during gait are higher in diabetes patients with chronic foot
ulcers than controls at several plantar sites throughout prolonged follow-up. Long term off-
loading is needed in diabetes patients with diabetes-related foot ulcers to facilitate ulcer
healing.
Introduction
Patients with diabetes-related foot ulcers (DFUs) have poor health-related quality of life and
are at risk of prolonged hospitalisations [1–3]. DFUs frequently fail to heal and can remain
stagnant in the inflammatory phase of healing increasing the risk of infection and limb ampu-
tation [4–8]. Therefore expediting the healing of DFUs is of paramount importance [1, 9, 10].
High plantar pressures have been implicated in the development of DFU by increasing the
mechanical stress experienced by plantar tissue in the presence of diabetic peripheral neuropa-
thy (DPN) [11–13]. Previous cross-sectional studies have reported that the pressures measured
at specific plantar sites and resultant tissue stresses during gait are higher in people with active
DFUs than controls [14–16]. Hence a frequent cause of delayed healing of DFUs is thought to
be high plantar pressures during gait [14, 17, 18–19]. Studies have demonstrated much shorter
DFU healing times when plantar stresses on ulcerated tissues were reduced by using offloading
devices (such as total contact casts or removable cast walkers) [18]. It has also been suggested
that patients with DFUs may adapt to these tissue stresses via the development of an alternative
gait strategy to reduce plantar pressures [20, 21]. However, no longitudinal study has previ-
ously examined plantar pressures in patients with chronic DFUs [14, 19]. Therefore, measur-
ing plantar pressures in people with DFUs during ulcer healing could provide importance
guidance to pressure-offloading approaches with the aim of improving wound healing.
The aim of this study was to investigate plantar pressures at baseline and three and six
months later in participants with DFUs (cases) compared to participants without DFUs (con-
trols). We hypothesised that cases with DFUs would have significantly higher plantar pressures
at baseline compared to controls and that these plantar pressure differences would remain dur-
ing follow-up at three and six months.
Methods
Study design and setting
This was a longitudinal study which was nested in a case-control study. The study protocol
and the baseline results of the study were previously published [14, 19]. All participants
attended the Movement Analysis Laboratory, James Cook University, Townsville, Queensland,
Australia on three separate occasions (baseline, first-follow-up at three months and second fol-
low-up at six months) between July 2012 to November 2014.
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Participants
Twenty one participants with active unilateral plantar DFUs of more than 3 months duration
(cases) and 69 type 2 diabetes mellitus participants without ulcers (controls) were initially
recruited for this longitudinal study [19]. Inclusion criteria for the cases included adults (18
years or older) with a confirmed diagnosis of type 2 diabetes and a single active unilateral plan-
tar DFU of longer than three months duration with an ankle-brachial pressure index (ABPI)
greater than 0.8 in both limbs [19]. All patients with DFU had neuropathic DFUs. The control
group comprised of adults with a confirmed diagnosis of type 2 diabetes without a history of
DFUs and an ABPI greater than 0.8 in either limb [19]. The exclusion criteria were designed to
avoid inclusion of participants with other conditions impacting on mobility or a condition
that would likely mask the impact of a plantar foot ulcer on gait such as severe arthritis or a
prior history of knee arthroplasty and have been detailed previously [19]. All participants were
recruited from the Townsville Hospital and Health Service District, in Queensland, Australia
between July 2012 and May 2014. The study was approved by two human research ethics com-
mittees (HREC): The Townsville Hospital HREC and the James Cook University HREC,
(approval numbers HREC/12/QTHS/77 and H4693, respectively). Written informed consent
was obtained from all participants [19].
Participant characteristics
All anthropometric, haematological and clinical measurements were performed according to
the study protocol [19]. Measures such as age, height, sex, ethnicity, monofilament sensation,
the Michigan Neuropathy Symptom and Physical Assessment Scores and ABPIs were only
assessed at baseline [14, 19, 20]. Each participant’s weight, body mass index (BMI), body fat
percentage and waist and hip circumference, ulcer area, University of Texas Wound Classifica-
tion Score (UTWCS) [19], glycated haemglobin A1c (HbA1c) and estimated glomerular filtra-
tion rate (eGFR) [19] were measured at each study-visit. We screened both cases and controls
for the presence of DPN using several different methods following recognised guidelines [21,
22] and as detailed in our study protocol [19]. The screening consisted of using a 10g (size
5.07) monofilament sensation test at twenty plantar locations, a 128 Hz tuning fork sensation
perception test and administration of the Michigan neuropathy screening instrument (MNSI)
[19]. Where a participant was unable to detect the monofilament at five or less sites out of
eight pre-defined sites, they were considered to have DPN [23]. Additionally, vibration sensa-
tion was assessed on a scale of 0 to 8 in each leg based on the number of times vibration com-
mencement and cessation was felt accurately [24]. The same assessor (MEF) carried out all
assessments. Good-to-excellent reproducibility (concordance correlation coefficients between
0.999 [95% Confidence Interval (CI): 0.999–0.999] and 0.998 [95% CI: 0.995–0.999]) were pre-
viously reported for all measurements performed in the study [25].
All participants received standard care between follow up visits external to their involve-
ment in the study [18]. For cases this typically comprised of assessment and treatment of the
ulcer by a podiatrist at least once every four weeks [18]. Most controls attended an annual
foot-check with a podiatrist as suggested in National guidelines and had regular review of their
diabetes control with a General Practitioner or Endocrinologist [18].
Procedure used to measure plantar pressures
The Footscan1 pressure plate (RSscan International, Olen, Belgium) was used for plantar
pressure assessment along with the associated Foot Scan 1 processing software. Plantar pres-
sures were measured in both feet at baseline, three and six months follow-up visits. All cases
with DFUs were given a standard single-layer generic film wound dressing to wear over the
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wound during gait examination to minimise the impact of wound dressings on the study
results and to standardise the type of dressing during gait assessments and to minimise the risk
of wound infection [19]. The dressings which were placed over the plantar foot ulcer remained
intact for the entire duration of walking. In addition to the generic film adhesive, all dressings
were further supported and reinforced using a single layer of hypoallergenic adhesive dressing
tape. After data collection on the day of the visit, the ulcer site was cleaned with saline solution,
disinfected and re-dressed with an appropriate foam dressing. The patient returned to their
regular wound care appointment thereafter as per routine clinical care. The movement analysis
laboratory floors were disinfected using a hospital grade disinfectant daily at the start and the
end of the day. In addition, as a precautionary measure, participants with DFUs were only
requested to weight bear while gait and plantar pressure assessments were being carried out
and they were instructed to remain sitting with their feet off the ground as much as possible
between assessments.
The validated three step approach for plantar pressure measurement was used [26]. A stan-
dard protocol for collecting plantar pressure data during gait was used with five assessments
per participant for obtaining individual averages [19]. The pressure measurement software
permitted masking of the foot to enable identification of plantar pressures at ten plantar sites
in each foot. The sites included the plantar surfaces of the hallux, toes two to five, metatarsal
one, metatarsal two, metatarsal three, metatarsal four, and metatarsal five, the mid-foot, the
lateral heel and the medial heel. Mean peak plantar pressure (mpp) in N/cm2 and pressure-
time integral (pti) in Ns/cm2 were the outcomes of interest for this study [19]. The mpp relates
to the average peak pressure during a single step at a particular site. The pti is the area under
the pressure-time curve and describes a pressure value for the total load exposure of a specific
plantar site during a single step [27]. We previously reported that the coefficients of variation
(CVs) were below 30% for 17 out of 20 mpp measurements, whereas the CVs were below 30%
for 14 out of 20 pti measurements [25].
Statistical analysis
The normality of continuous data was assessed using the Shapiro-Wilk test. Categorical data
were reported as numbers and percentages (%) and continuous data were reported as means
and standard deviations (SD), mean differences (Δ) or medians and interquartile ranges
(IQRs) depending on the distribution of data. Characteristics of cases and controls were com-
pared with Student’s t-test, Pearson’s chi-square test or Fisher’s exact test when assumptions
for Chi-square tests were not met. We compared plantar pressures of ulcerated feet to plantar
pressures averaged from the left and right feet of controls. Differences in mpp and pti over
time were examined using linear mixed effects random-intercept models with individual par-
ticipants as random effects and ulcer presence, months of follow-up, age, sex, body mass index
(BMI) and the presence of neuropathy as fixed effects. The fixed effects were selected based on
their previously established influence on plantar pressures [14, 20]. Within our statistical mod-
els, we assessed whether there was an association between ‘time’ and any changes in plantar
pressure in all participants. We used an ‘interaction’ term within mixed effects models to assess
whether any changes in plantar pressure over time differed between cases and controls. Where
no significant interaction existed between ulcer presence and plantar pressures over time, the
models were repeated excluding the interaction term.
Results of linear mixed effects models were reported using t-values, degrees of freedom (df)
and p-values for estimated coefficients. Analysis of variance (ANOVA) was used to assess the
overall goodness of fit of the linear mixed models for plantar pressure comparisons and
changes over-time (see S1 and S2 Files). ANOVA results were reported in the main results as a
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measure of statistical significance. The statistical significance of outcomes was considered first
by assessing the p-value obtained from ANOVA and then by assessing the p-value from the
table of coefficients. When both p values were less than 0.05, a result was considered statisti-
cally significant. Standardised mean differences (Cohen’s d values) were calculated for all
outcomes which were significantly different between groups using a previously published for-
mula: standardised mean difference (d) = t (2/n) 1/2 [28, 29]. The size and direction of the dif-
ference was graded based on Cohen’s d as: <0.10 trivial difference; 0.10–0.20 small difference;
0.20–0.60 medium difference; 0.60–1.20 large difference and1.20 a very large difference
[30].
In order to assess the impact of ulcer healing during follow-up we performed sensitivity
analyses excluding participants with healed ulcers (see S3 File). These analyses showed similar
results to those obtained by analysing all participants and therefore we have presented the lat-
ter results. SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for the statistical
comparisons of baseline demographic characteristics. The R (R Core Team, 2015) software
was used for analysis of all longitudinal data with the ‘nlme’ package [31] for the mixed- effects
models and for examining residual plots to check for deviations from homoscedasticity and
normality assumptions. Summary plots of pti and mpp at the ten plantar sites were created for
each time point (Figs 1 and 2).
Fig 1. Site-specific mean peak pressures over time in participants with DFUs and participants without DFUs. Figure indicates the mean peak
pressure at ten plantar sites in cases (red) and diabetes controls (DM controls) (green) at each visit. The x-axis has been scaled to allow for better data
visualisation. All values are in N/Cm2 and are reported for 10 plantar foot sites. T1 = hallux (big-toe), T2-5 = toes two to five, M1 = metatarsal one,
M2 = metatarsal two, M3 = metatarsal three, M4 = metatarsal four, M5 = metatarsal five, Mid = mid-foot, HM = medial heel and HL = lateral heel.
https://doi.org/10.1371/journal.pone.0181916.g001
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Results
Recruitment and attrition of participants
Ninety participants commenced the study and were assessed at baseline (21 cases and 69 con-
trols). Of those, five (24%) cases and six (9%) controls did not complete all follow-up visits.
Prior to the three month follow-up visit [IQR 3–4 months], three cases (two due to orthopae-
dic surgery and one due to acute lower back pain) and two controls (one due to coronary
artery bypass and one due to inability to attend) withdrew from the study. Prior to the six
month follow-up visit [IQR 6–11.5 months], another three controls (one due to acute illness
and two due to inability to attend and three cases (two due to hospitalisation and one due to
inability to attend) also withdrew.
Participant characteristics at baseline
The baseline data from this cohort were reported in an earlier manuscript [14]. Table 1 dis-
plays the baseline characteristics of the 21 cases and 69 controls that were initially recruited.
There were no significant differences in age, sex, ethnicity, BMI, average HbA1c, smoking sta-
tus or leg length between cases and controls at baseline. The presence of hammer-toe defor-
mity was more common in cases at baseline (p = 0.006).
Fig 2. Site-specific pressure-time integrals over time in participants with DFUs and participants without DFUs. Figure indicates the pressure-
time integral at ten plantar sites in cases (red) and diabetes controls (DM controls) (green) at each visit. The x-axis has been scaled to allow for better
data visualisation. All values are in Ns/Cm2 and are reported for 10 plantar foot sites. T1 = hallux (big-toe), T2-5 = toes two to five, M1 = metatarsal one,
M2 = metatarsal two, M3 = metatarsal three, M4 = metatarsal four, M5 = metatarsal five, Mid = mid-foot, HM = medial heel and HL = lateral heel.
https://doi.org/10.1371/journal.pone.0181916.g002
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Table 1. Clinical and demographical characteristics of the enrolled study cohort at baseline.
Variable Cases (n = 21) Controls (n = 69) p-value
Age at enrolment (years) 63.1 (± 10.6) 63.4 (± 9.6) 0.905
Males 15 (71.4%) 46 (66.7%) 0.793
Ethnicity 1.000
Caucasian 20 (95.2%) 65 (94.2%)
Australian Aboriginal/Indigenous/Torres-strait Islander 1 (4.8%) 2 (2.9%)
Other 2 (2.9%)
Diabetes duration [years]# 16.6 (± 7.1) 10.7 (± 8.6) 0.005
HbA1c (mmol/l)# 58.9 (± 16.8) 54.8 (± 13.3) 0.284
Uses Insulin# 13 (61.9%) 19 (27.5%) 0.005
Smoking Status 0.443
Never Smoker 14 (66.7%) 34 (49.3%)
Ex-Smoker 6 (28.6%) 29 (42.0%)
Current Smoker 1 (4.8%) 6 (8.7%)
History of hypertension 19 (90.5%) 46 (66.7%) 0.049
History of dyslipidaemia 14 (66.7%) 45 (65.2%) 1.000
History of stroke* 2 (9.5%) 2 (2.9%) 0.231
History of coronary heart disease 7 (33.3%) 18 (26.1%) 0.581
History of chronic heart failure 3 (14.3%) 9 (13.0%) 1.000
History of chronic pulmonary disease 4 (19.0%) 14 (20.3%) 1.000
History of chronic liver disease 2 (9.5%) 5 (7.2%) 1.000
History of chronic renal impairment 5 (23.8%) 10 (14.5%) 0.506
Height [cm] 173.7 (± 9.8) 169.6 (± 10.6) 0.121
Weight [kg] 102.5 (± 23.8) 91.3 (± 15.2) 0.012
BMI [Body Mass Index] [kg/m2] 34.0 (± 8.3) 31.8 (± 4.80) 0.120
Body Fact Percentage [% bf] 28.5 (± 13.7) 27.8 (± 12.6) 0.834
Waist Circumference [cm] 113.5 (± 17.9) 106.6 (± 11.2) 0.035
Hip Circumference[cm] 110.7 (± 18.9) 105.8 (± 10.2) 0.120
Left leg length [cm] 91.8 (± 7.1) 90.5 (± 5.6) 0.390
Right leg length [cm] 92.9 (± 8.0) 89.9 (± 11.4) 0.266
ABPI^ 1.1 (± 0.2) 1.1 (± 0.2) 0.913
Monofilament score 7 (± 7) 18 (± 4) <0.001
MNSI symptom score# 7 (± 1) 5 (± 2) <0.001
MNSI physical assessment score# 7 (± 1) 2 (± 2) <0.001
Foot-type 0.166
Pes planus foot type 14 (66.7%) 29 (42.0%)
Normal arched foot type 4 (19.0%) 23 (33.3%)
Pes cavus foot type 3 (14.3%) 17 (24.6%)
First MTPJ RoM (degrees) 35.8 (± 14.4) 43.1 (± 15.1) 0.052
Ankle Joint RoM (restricted dorsiflexion) 17 (81.0%) 51 (73.9%) 0.897
Subtalar Joint RoM (restricted inversion/eversion) 2 (9.5%) 3 (4.4%) 0.703
Hallux Abducto Valgus deformity [32] 0.955
(No deformity) 14 (66.7%) 51 (73.9%)
(Grade 1) 5 (23.8%) 13 (18.8%)
(Grade 2) 1 (4.8%) 3 (4.3%)
(Grade 3) 1 (4.8%) 2 (2.9%)
Claw toe deformity 6 (28.6%) 11 (15.9%) 0.213
Hammer toe deformity 12 (57.1%) 16 (23.2%) 0.006
(Continued )
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Participant characteristics during follow-up
Table 2 displays the anthropometric characteristics at baseline and the first and second follow-
up visits for cases and controls. All cases had DFUs on the plantar aspect of the foot, including
16 ulcers (76.2%) under the fore-foot and five ulcers (23.8%) under the rear-foot. Most DFUs
(81.0%) were superficial with a UTWCS grade of A1 or B1 [n = 17 (80.9%)] and the remainder
extended to tendon or capsule [A2 = 3 (14.3%) and B2 = 1 (4.8%)]. Controls had a slightly lon-
ger follow-up period compared to cases (Table 2). There was a small decrease in the mean ulcer
area at the first follow-up (Δ = 0.4 [SD = 0.8] mm2) and a slight increase in mean ulcer area at
the second follow-up (Δ = 3.4 [3.6] mm2). The stance phase duration seemed to be longer in
cases compared to controls throughout follow-up. Four (19.0%) DFUs healed during follow-up
and remained healed (see Table 2). None of the controls developed DFUs during follow-up.
Plantar pressure outcomes
Mean peak pressure. Cases had a significantly higher mpp at toes 2–5 (p = 0.005,
d = 0.36) and the mid-foot (p = 0.010, d = 0.36) throughout follow-up compared to controls
(see Table 3 and S1 File). Conversely, cases had a significantly lower mpp at metatarsal 4 com-
pared to controls throughout follow-up (p = 0.017, d = -0.38) (see Table 3 and S1 File). Mpps
decreased during follow-up at some sites including toes 2–5 (p<0.001, d = -0.38), metatarsal 1
(p = 0.005, d = -0.18) and the mid-foot (p<0.001, d = -0.36) in all participants (see Table 3 and
Fig 1). The interaction term was insignificant between cases and controls.
Pressure-time integral. Cases had significantly higher ptis at the hallux (p<0.001,
d = 0.42), plantar metatarsal 1 (p = 0.02, d = 0.33), the mid-foot (p = 0.040, d = 0.64), the medial
heel (p = 0.020, d = 0.20) and the lateral heel (p = 0.030, d = 0.31) throughout follow-up com-
pared to controls (see Table 4 and S2 File). The pti at the hallux (p = 0.020, d = -0.20), all meta-
tarsals, including metatarsal 1 (p<0.001, d = -032) and the mid-foot (p<0.001, d = -0.33)
decreased during follow-up in all participants (see Table 4 and Fig 2).
Discussion
The main finding from this study was that plantar pressures (mpp and pti) were higher at mul-
tiple sites in cases with chronic DFUs compared to diabetes controls throughout a six month
follow-up period. Overall, mpps and ptis at several sites significantly reduced over time in all
participants. Although shorter wound healing times have been achieved by reducing plantar
Table 1. (Continued)
Variable Cases (n = 21) Controls (n = 69) p-value
Mallet toe deformity 3 (14.3%) 14 (20.3%) 0.752
All data represents mean (± standard deviation) or number and percentages (%). Cases = foot ulcer group, controls = diabetes mellitus control group
without ulcers. The reported test statistic indicates the t-statistic or Pearson’s Chi-square or Fisher’s exact test values with associated degrees of freedom.
The reported p-values indicate main comparison outcomes from student’s t-tests, Pearson’s Chi squared tests or Fishers exact tests between groups. A
significance level of p <0.05 was used throughout. Diabetes duration indicates fractions of years living with type 2 diabetes mellitus.
^ Ankle Brachial pressure Index = ABPI. ABPI values represented in the table are for ulcerated limbs of the Cases groups and the lowest reported in the
control group. Monofilament score is out of a total of 20, measured at ten sites for each foot. MNSI scores indicate the total scores from the Michigan
Neuropathy Screening Instrument in relation to the neuropathy symptom score and physical assessment score.
* Note that the four patients with stroke did not have a history of gait disturbance due to their stroke as the stroke only affected their speech function. Hallux
Abducto Valgus (HAV) deformity grades were based on the Manchester scale as reported in the study protocol. RoM = Range of motion, restricted
dorsiflexion incorporated people with < 10 degrees dorsiflexion.
https://doi.org/10.1371/journal.pone.0181916.t001
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stresses on ulcerated tissue using offloading devices [18], whether plantar pressures actually
remained elevated in people with chronic DFUs was largely unknown. The results from this
study provide convincing evidence that plantar pressures remain elevated in people with
DFUs and emphasise the need for long term pressure offloading in patients with chronic
neuropathic DFUs to expedite and encourage ulcer healing, which is an important clinical
consideration.
A number of longitudinal studies have previously assessed the association of plantar pres-
sures with the subsequent risk of developing DFUs [34–37]. However, we are not aware of any
longitudinal studies that have prospectively investigated plantar pressures in patients with
existing active DFUs as reported here. Our findings suggest that patients with active DFUs
have on-going higher plantar pressures at multiple sites by comparison to controls [14]. Boul-
ton et al. (1987) reported that changes in the levels of plantar pressure may occur during a rela-
tively short time in participants with DPN; however measurement repeatability needs to be
considered in interpreting such data [35].
Our findings also suggest that overall plantar pressures reduced during repeated assess-
ment. One possible reason for this is a familiarisation effect with repeated plantar pressure
assessment. A previous study reported reductions in plantar pressure from baseline to follow-
up for a majority of plantar sites in healthy participants [38]. This may indicate that as partici-
pants become more familiar with the walking environment and the plantar pressure protocol
[19, 25], their plantar pressures show a relative reduction. These findings have some implica-
tions for researchers collecting plantar pressure data and may indicate that collecting plantar
Table 2. Clinical and demographic characteristics of the study cohort at each follow-up.
Cohort at each follow-up
Variable Cases (n = 21) Cases (n = 19) Cases (n = 16) Controls (n = 69) Controls (n = 66) Controls (n = 63)
Baseline 1st follow-up 2nd follow-up Baseline 1st follow-up 2nd follow-up
Number of months since baseline median
[IQR]
- 3.0 [3.0–4.0] 6.0 [6.0–8.0] - 4.0 [3.0–4.0] 9.0 [6.0–12.0]
Males (%) 15 (71.4%) 13 (68.4%) 12 (75.0%) 46 (66.7%) 45 (68.1%) 44 (69.8%)
Weight [kg] (SD) 102.6 (± 23.8) 106.9 (± 23.1) 108.5 (± 21.6) 91.3 (± 15.2) 91.0 (± 14.6) 91.4 (± 14.4)
BMI [Body Mass Index] [kg/m2] (SD) 34.0 (± 8.3) 35.3 (± 8.4) 35.6 (± 8.2) 31.8 (± 4.80) 31.4(± 4.7) 31.7 (± 4.8)
Body Fat Percentage [% bf] (SD) 28.5 (± 13.7) 27.5 (± 13.5) 26.0 (± 14.3) 27.8 (± 12.6) 27.5 (± 1.3) 29.6 (± 13.0)
Waist Circumference [cm] (SD) 113.5 (± 17.9) 106.0 (± 17.8) 109.0 (± 22.1) 106.6 (± 11.2) 105.0(± 10.0) 105.0 (± 10.2)
Hip Circumference[cm] (SD) 110.7 (± 18.9) 104.7 (± 9.7) 108.0 (± 11.3) 105.8 (± 10.2) 103.0 (± 9.3) 103.0 (± 9.3)
Stance phase duration (ms) (SD) 836 (± 115) 747 (± 99) 799 (± 137) 749 (± 93) 743 (± 57) 736 (± 56)
Ulcer grade (UTWCS) [33]
A0 - 2 (10.5%) 4 (25.0%)
A1 16 (76.2%) 14 (73.7%) 8 (50.0%)
A2 3 (14.2%) 1 (5.3%) 1 (6.2%)
A3 - - -
B1 1 (4.7%) 2 (10.5%) 3 (18.8%)
B2 1 (4.7%) - -
Average ulcer area (mm2)* 20.3 (± 18.8) 19.9 (± 18.0) 23.3 (± 21.6)
Data represents mean (± standard deviation; SD) or number and percentages (%), or median and [inter-quartile range; IQR]. Cases = foot ulcer group,
controls = diabetes mellitus control group without foot ulcers. UTWCS = University of Texas Wound Classification Score. A0 = healed ulcer with complete
epithelisation, A1 = superficial ulcer, A2 = ulcer which is down to the level of soft tissue, A3 = ulcer which is down to the level of bone, B1 = infected
superficial ulcer, B2 = infected ulcer which is down to the level of soft tissue.
* Ulcer area was calculated excluding healed ulcers.
https://doi.org/10.1371/journal.pone.0181916.t002
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pressure data over several observations may lead to small gradual reductions in measurements.
However, as the reductions in pressures occurred overall and as the sites identified to have
the highest plantar pressures in cases compared to controls were similar throughout follow-
up, whether there is added value in repeated plantar pressure measurements is uncertain [25,
39–41].
Our results support the need for sustained pressure offloading in patients with a history of
chronic DFUs. Whether long term monitoring of plantar pressures can improve management
of DFUs is controversial. Bus et al. (2011) suggested the use of in-shoe plantar pressure assess-
ments to better inform pressure off-loading in participants with DPN at risk of developing
DFU [42]. Despite this, a number of studies have suggested that plantar pressures are not rou-
tinely assessed in clinical practice [43, 44]. At present, very few centres around the world rou-
tinely utilise plantar pressures to ascertain levels of required offloading for patients at risk of
DFUs [45, 46]. The high level of intra-participant, intra-device and inter-device variability of
plantar pressure measurements is considered a deterrent to its routine use in clinical practice
[25, 47]. This is a major limitation which needs further attention and improvement. Irrespec-
tive of this, plantar pressure measurements may indirectly assist in improving patient compli-
ance with pressure offloading. One of the challenges for clinicians when communicating the
importance of offloading with patients is the inability to demonstrate the need visually. The
visualisation of plantar pressures using pressure measurements, in addition to quantitatively
assessing the level of pressure, may provide an incentive to obtain better patient compliance
with off-loading [48, 49].
A key area of future research focus in the field should be to characterise the important pre-
dictors of elevated plantar pressures in people with active DFUs. Recent work has outlined that
foot-deformity and foot structure may be predictors of higher mid-foot plantar pressure in
people with DPN and a history of DFUs [50]. Although we did not observe a statistical differ-
ence in the foot types between cases and controls, the higher mid-foot plantar pressures in
cases may have been due to the presence of pes-planus foot-type. Other work has also identi-
fied that an increase in the viscoelasticity of plantar soft tissues, especially at the first metatarso-
phalangeal joint may be a crucial factor for elevated peak plantar pressures in people with
DPN [51]. More recent work has outlined that new measures of plantar pressure such as the
pressure gradient angle which quantifies the time-varying directions of plantar pressure may
provide more valuable information regarding the plantar stressors experienced by people with
DPN [52]. Whether measuring the viscoelasticity of plantar tissue and pressure gradient angles
in people with active DFUs provides more insight on the biomechanical mechanisms underly-
ing delayed wound healing is uncertain.
The limitations of our study include a small sample size in combination with a rather large
number of statistical comparisons, the limited number of co-variates able to be used in statisti-
cal analyses and the inability to assess the association of plantar pressure and ulcer healing due
to a small number of healed ulcers. It is also likely that reductions in plantar pressures that
were observed were more representative of controls rather than cases as we had more controls
than cases. The poor healing rate observed in our study (4 DFUs or 19% during six months fol-
low-up) is representative of the inclusion criteria we used (i.e. people with DFUs of more than
3 months duration). Hence our results are representative of people with chronic DFUs and
supports our earlier finding that following DFU healing, plantar pressures remain higher in
people with a history of DFUs [53]. Therefore our results may not be applicable to people with
DFUs of less than 3 months duration. A small increase in ulcer size at the second follow-up
may have been due to cases with healing DFUs dropping out of the study, whereas cases with
poorly healing DFUs remained. The length of follow-up varied between individuals and
between the two groups; however, this was adjusted for in our analyses. A longer follow-up
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period may have provided further clarity on the relationship between elevated plantar pres-
sures and ulcer healing, although this would have been limited by attrition.
As mentioned earlier, site specific mpp and pti have a variable level of reproducibility with
repeated observations which may have also influenced our follow-up results [25]. We assessed
barefoot plantar pressure rather than in-shoe pressure, as we wanted to investigate the foot-
ground interaction in patients with DFUs without the influence of footwear. Our plantar pres-
sure results seem to be lower than other values reported in the literature [16], but are consis-
tent with other data obtained using the same pressure measurement system in participants
with diabetes [54]. We assessed whether the reductions in plantar pressures over time were
due to attrition of participants with higher plantar pressures at baseline, however excluding
participants who were lost to follow-up did not influence the reductions of plantar pressure
over time.
The strengths of this study include the longitudinal design, the reporting of reproducibility
prior to data collection [25] and the use of statistical models to adjust plantar pressure out-
comes for a number of key confounding factors including the presence of neuropathy. Our
attrition rate was also significantly lower than the rate thought to be acceptable within the
field. Our analyses accounted for numbers lost to follow-up and any differences in outcomes
due to differences in follow-up times and the sample composition over time.
Our results highlight the importance of offloading in the long-term management of people
with DFUs [18]. As the ideal percentage of plantar pressure reduction required to facilitate
ulcer healing is yet to be determined [55], offloading efforts should aim to reduce plantar pres-
sures as much as possible, using a 30% reduction recommended to prevent DFU development
as a guide [45]. Given our results indicating that plantar pressures may show natural reduc-
tions during follow-up, it is imperative that clinicians should appreciate that natural changes
in plantar pressures could occur with time. Future work should focus on how best to utilise
plantar pressures in managing and preventing DFUs and in identifying alternate methods of
reducing plantar pressure during gait [20].
Conclusion
The findings from this study suggest that plantar pressures assessed during gait are higher in
diabetes patients with chronic DFUs than controls throughout prolonged follow-up at several
plantar sites. Long term offloading is needed in diabetes patients with chronic DFUs to facili-
tate ulcer healing.
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